Antares Pharma, Inc. (AIS) Reports In-Line Q1 EPS
Tweet
Share
E-mailGet Alerts AIS Hot Sheet
Join SI Premium – FREE
Antares Pharma, Inc. (NYSE: AIS) reported Q1 EPS of ($0.02), in-line with the analyst estimate of ($0.02). Revenue for the quarter came in at $3.57 million versus the consensus estimate of $3.24 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- McCormick & Co. (MKC) Tops Q3 EPS by 10c, Beats on Revenue; Offers EPS Guidance
- Cal-Maine Foods stock edges down on first quarter loss and revenue miss
- Bassett Furniture Industries (BSET) Tops Q3 EPS by 11c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
